Immunovant, Inc.: COO Gloria Melanie sold 2,241 shares

What happened

• Gloria Melanie, chief operating officer, sold 2,241 shares on Oct 7, 2026, at a weighted average price of $32.06 for proceeds of $71,846. The sale is reported as an S (sale) transaction.
• The filing states the sale was to cover tax withholding related to the vesting and settlement of restricted stock units granted Apr 1, 2025; 4,761 RSUs vested on Oct 1, 2026.

Key details

• Transaction date and prices: Oct 7, 2026; weighted average price $32.06; prices ranged $31.58–$32.30 (footnote F2).
• Shares sold: 2,241; proceeds $71,846.
• RSU context: 76,181 RSUs were originally granted Apr 1, 2025; 4,761 RSUs vested Oct 1, 2026 (footnote F1).
• Shares owned after the transaction (from the vested lot): 4,761 vested shares minus 2,241 sold = 2,520 vested shares remaining from that vesting event.
• Reason reported: sale mandated by issuer’s election to satisfy tax withholding via a "sell to cover" and was not a discretionary transaction by the reporting person (footnote F1).
• Filing and report dates: Period of report Oct 7, 2026; Form filed Oct 9, 2026.

Why it may matter

• The filing shows the sale was a sell-to-cover tax withholding following RSU vesting, not a discretionary market sale.
• A filing does not show why the insider traded or why the company acted.